medigraphic.com
SPANISH

Revista ADM Órgano Oficial de la Asociación Dental Mexicana

ISSN 0001-0944 (Print)
Órgano Oficial de la Asociación Dental Mexicana
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2020, Number 3

<< Back Next >>

Rev ADM 2020; 77 (3)

Gorlin-Goltz syndrome. Molecular diagnosis, new treatments

Olmedo-Cueva S, Velazco TM, Castilla CH, Salgado-Chavarría F
Full text How to cite this article 10.35366/94011

DOI

DOI: 10.35366/94011
URL: https://dx.doi.org/10.35366/94011

Language: Spanish
References: 23
Page: 162-167
PDF size: 307.32 Kb.


Key words:

Gorlin-Goltz syndrome, basal cell carcinomas, keratocysts, Patched 1 gene.

ABSTRACT

Introduction: Gorlin-Goltz syndrome or cell-based nevus carcinoma syndrome is an autosomal dominant inherited disorder that predisposes mainly to the proliferation of multiple basal cell carcinomas, maxillary keratocysts and developmental defects, caused by the mutation of the Patched gene located on chromosome 9. Case presentation: A patient with specific characteristics compatible with this syndrome was reported in the COMF Department of the UNAM. The diagnosis was based on clinical studies, radiology and genetic studies. Conclusions: Knowledge of this problem can guide us to the diagnostic suspicion in a timely manner, thus preventing complications, and to provide an improved integral treatment of the quality of life of this type of patients.


REFERENCES

  1. Gorlin RJ, Goltz RW. Multiple nevoid basal cell epithelioma, jaw cyst and bifid rib. A syndrome. N Engl J Med. 1960; 262: 908-912.

  2. Gorlin R. Nevoid basal cell carcinoma syndrome. Medicine (Baltimore). 1987; 66: 98-113.

  3. Hahn H, Wicking C, Zaphiropoulous P, Gailani M, Shanley S, Chidambaram A. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell. 1996; 85: 841-851.

  4. Epstein EH. Basal cell carcinomas: attack of the hedgehog. Nat Rev Cancer. 2008; 8: 743-754.

  5. Evans D, Farndon P. Nevoid basal cell carcinoma syndrome. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, BeanLJH et al., editors. Gene reviews [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2015 [actualización 1 Oct 2015].

  6. Wong SY, Dlugosz AA. Basal cell carcinoma. Hedgehog signaling, and targeted therapeutics: the long and winding road. J Invest Dermatol. 2014; 134: E18-E22.

  7. Evans DG, Howard E, Giblin C, Clancy T, Spencer H, Huson SM et al. Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am JMed Genet A. 2010; 152A: 327-332.

  8. Lo Muzio L, Pastorino L, Levanat S, Musani V, Situm M, Ponti G et al. Clinical utility gene card for: Gorlin syndrome update 2013. Eur J Hum Genet. 2013; 21: 1-3.

  9. Farndon PA, del Mastro RG, Evans DG, Kilpatrick MW. Location of gene for Gorlin syndrome. Lancet. 1992; 339: 581-582.

  10. Wilding A, Ingham SL, Lalloo F, Clancy T, Huson SM, Moran A et al. Life expectancy in hereditary cancer predisposing diseases: an observational study. J Med Genet. 2012; 49: 264-269.

  11. Lo Muzio L. Nevoid basal cell carcinoma syndrome (Gorlin syndrome). Orphanet J Rare Dis. 2008; 3: 32.

  12. Tom WL, Hurley MY, Oliver DS, Shah MR, Bree AF. Features of basal cell carcinomas in basal cell nevus syndrome. Am J Med Genet A. 2011; 155A: 2098-2104.

  13. Akbari M, Chen H, Guo G, Legan Z, Ghali G. Basal cell nevus syndrome (Gorlin syndrome): genetic insights, diagnostic challenges, and unmet milestones. Pathophysiology. 2018; 25 (2): 77-82.

  14. Joshi PS, Deshmukh V, Golgire S. Gorlin-Goltz syndrome. Dent Res J. 2012; 9 (1): 100-106.

  15. Kimonis VE, Goldstein AM, Pastakia B, Yang ML, Kase R, DiGiovanna JJ et al. Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. Am J Med Genet. 1997; 69: 299-308.

  16. Wallace DL, Jaffe W. Reply to: do basal cell carcinomas recur after complete conventional surgical excision? R.W. Griffiths, S.K., Suvarna. J Stone BJPS. 2005;58:795-805. J Plast Reconstr Aesthet Surg. 2006; 59: 1247.

  17. Jones JEA, Sajid MI, Shenton A, Evans DG. Basal cell carcinomas in Gorlin syndrome: a review of 202 patients. J Skin Cancer. 2011; 2011: 217378.

  18. Bree AF, Shah MR, BCNS Colloquium Group. Consensus statement from the first international colloquium on basal cell nevus syndrome (BCNS). Am J Med Genet A. 2011; 155A: 2091-2097.

  19. Ratcliffe J, Shanley S, Ferguson J, Chenevix Trench G. The diagnostic implication of falcine calcification on plain skull radiographs of patients with basal cell naevus syndrome and the incidence of falcine calcification in their relatives and two control groups. Br J Radiol. 1995; 68: 361-368.

  20. Kiwilsza M, Sporniak-Tutak K. Gorlin Goltz syndrome - a medical condition requiring a multidisciplinary approach. Med Sci Monit. 2012; 18: RA145-RA153.

  21. Lam C, Ou JC, Billingsley EM. PTCH-ing it together: A basal cell nevus syndrome review. Dermatol Surg. 2013; 39: 1557-1572.

  22. Rosón-Gómez S, González-García R, Naval-Gías L, Sastre-Pérez J, Muñoz-Guerra MF, Díaz-González FJ. Síndrome de Gorlin-Goltz: serie de 7 casos. Rev Esp Cirug Oral y Maxilofac. 2009; 31 (5): 309-315.

  23. Escamilla OC, Sánchez LR, Sánchez GL, Treviño AM, Martínez MH, Rivera SG. Síndrome de Gorlin-Goltz reporte de un caso clínico. Rev ADM. 2013; 70 (1): 43-45.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev ADM. 2020;77